LCLionel Cailhol

Lionel Cailhol

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lionel Cailhol has a total of 139 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Understanding stakeholder views on dialectical behavior therapy for post-traumatic stress disorder: a qualitative analysis of clinician and patient experiences

    by Laurie Nadeau, Émiliane Larrivée, Anne-Sophie Paré, Christine Therriault, Alain Taillefer, Florence Charest, Alexandre Hudon, Félix-Antoine Bérubé, Lionel Cailhol

    Background: Individuals with Borderline Personality Disorder (BPD) and Complex Post-Traumatic Stress Disorder (C-PTSD) often face significant challenges in treatment due to the severity and complexity of their symptoms. Dialectical Behavior Therapy for PTSD (DBT-PTSD) is a phase-based, multicomponent psychotherapy developed to address the needs of this population. While its efficacy has been demonstrated in clinical trials, little is known about how patients and clinicians experience this treatment. Methods: This qualitative study explored the perspectives of six patients and five clinicians involved in DBT-PTSD at a university-affiliated mental health institute. Data were collected through individual interviews and focus groups at multiple time points and were analyzed inductively using Reflexive Thematic Analysis. Results: Five themes were generated, including trauma-focused exposure as a main mechanism of change, the role of the therapeutic alliance in supporting engagement and treatment outcomes, the demanding nature of trauma-focused exposure, the tension between fidelity and flexibility within the protocol, and the influence of individual resources on patients’ experiences with at-home assignments. Conclusions: This is the first study to qualitatively examine DBT-PTSD, providing insights into its perceived relevance, challenges, and potential impact. These findings may contribute to clinical training, guide adaptations of the protocol, and contribute to refining trauma interventions for individuals with BPD and C-PTSD. Clinical trials number: This trial was retrospectively registered on 14 August 2025, ClinicalTrials.gov , TRN: NCT07123974

  • Open Access

    Enhanced home-based transcranial direct-current stimulation (tDCS) for depression comorbid with borderline personality disorder (BPD): study protocol for a pilot double-blinded randomised controlled trial (TENTADIS)

    by Lionel Cailhol, Kamilia Soltani, David Benrimoh, Martin Blay, Sebastien Brodeur, Jérôme Brunelin, Caroline Dussault, Roxane Hoyer, Jillian Mills, Simon Poirier, et al.

    Introduction: Major depressive disorder (MDD) is the most common comorbidity among individuals with borderline personality disorder (BPD), affecting over 85% of patients and leading to high recurrence rates and resistance to treatment. Traditional pharmacological and psychotherapeutic interventions often show limited efficacy in this population, highlighting the need for innovative treatment strategies. Emerging evidence suggests that the dorsolateral prefrontal cortex (DLPFC) plays a crucial role in the pathophysiology of both MDD and BPD. In addition, non-invasive brain stimulation, particularly transcranial Direct Current Stimulation (tDCS), has shown promising results in alleviating depression and improving BPD symptoms when targeting the DLPFC. The development of home-based tDCS presents new opportunities for accessible and cost-effective interventions. However, no study has specifically investigated its effects on MDD in the context of BPD. Methods and analysis: This double-blind randomised controlled trial will assess the feasibility and explore the efficacy of home-based tDCS in reducing depressive symptoms in BPD patients who are experiencing moderate to severe depressive episodes. A total of 60 participants will be randomised, following a 2-week online psychoeducation, to receive either active or sham tDCS in 14 sessions over 1 week. The primary outcome is the feasibility of home-based tDCS in remote and urban areas. The secondary aim is to obtain a preliminary assessment of the efficacy of 14 home-based tDCS sessions in reducing depressive symptoms in BPD patients with moderate to severe depressive episodes and BPD symptoms. Exploratory analyses will evaluate the impact of tDCS on neuropsychological functioning, physical activity and substance use. Sociodemographic variables will be considered in predicting treatment response. All assessments will be conducted at baseline, post-treatment and during follow-ups through 3 months after treatment ends. Ethics and dissemination: This study has received approval from the Research Ethics Committee of the Centre intégré universitaire de santé et de services sociaux de l’Est-de-l’Île-de-Montréal (CIUSSS-EMTL) (approval number: MP-12-2025-4050). All participants will provide informed consent prior to inclusion. Findings will be disseminated through peer-reviewed publications, conference presentations and knowledge translation activities targeting clinicians, researchers and mental health stakeholders. Trial registration number: NCT06972368 .

  • Open Access

    Psychometric Properties of the FAB2 for Borderline Personality Disorder: A Swiss Validation

    by Julie J. Desrosiers, Anne Martine Bertrand Leiser, Charles-Edouard Giguère, Lionel Cailhol


  • Open Access

    Educational Approaches to Violence Risk Assessment and Management in Psychiatry and Psychology: A Scoping Review

    by Désirée Muller-Mallet, Béatrice Ouellon, Lionel Cailhol, Stéphanie Borduas Pagé, Alexandre Hudon

    Workplace violence and hetero-aggressive behavior represent significant occupational hazards in mental health settings, particularly for psychiatry and psychology trainees who are frequently exposed yet often insufficiently prepared. This scoping review aimed to map and critically describe existing educational approaches to violence risk assessment, prevention, and management in mental health training programs, with a focus on psychiatry and psychology education. A scoping review identified 17 eligible studies examining curricular content, pedagogical modalities, and training outcomes related to violence education. Included studies encompassed surveys, curricular descriptions, and educational interventions employing didactic, simulation-based, and blended learning formats. Overall, the literature revealed variability and fragmentation in training, with most programs lacking structured or longitudinal curricula. Didactic approaches improved conceptual understanding but were consistently perceived as insufficient for skill acquisition and confidence. In contrast, blended and simulation-based modalities, particularly those using standardized patients and structured debriefing, were associated with greater gains in applied skills, confidence, and perceived clinical readiness. Core competencies emphasized across curricula included de-escalation strategies, violence risk assessment frameworks, communication skills, and, less consistently, legal and institutional considerations. These findings highlight persistent educational gaps and support the integration of experiential, longitudinal, and system-informed training models to better prepare mental health trainees for violence-related clinical challenges.

  • Effet de l’exposition répétée à des scénarios émotionnels négatifs sur l’empathie et la variabilité du rythme cardiaque

    by Sara-Kim Boivin, Asmara Awada, Giuliano Lafrenière-Di Fruscia, Lionel Cailhol, Jean Gagnon

    Étant donné le manque de compréhension des mécanismes physiologiques de l’empathie dans la littérature, cette étude vise à explorer comment ceux-ci sont influencés par le type d’émotion et l’exposition répétée à des situations émotionnelles. Vingt-neuf participants ayant reçu un diagnostic de trouble de la personnalité ont effectué une tâche d’empathie impliquant quatre émotions négatives. Les données issues de mesures d’empathie situationnelle subjective et de variabilité du rythme cardiaque (VRC-HF) suggèrent un effet de l’émotion sur l’empathie subjective et une diminution de la VRC-HF avec l’exposition. Malgré le caractère exploratoire des résultats, les tailles d’effet justifient des recherches futures plus approfondies.

  • Open Access

    Effectiveness of mentalization-based therapy and dialectical behavior therapy for cluster B personality disorders: a naturalistic study of service utilization and treatment dropout

    by Phillip Yin, Simon Poirier, Arnaud Allary, Frédéric Pérusse, Pierre David, François-Samuel Lahaie, Lionel Cailhol

    Introduction: Mentalization-based therapy (MBT) and dialectical behavior therapy (DBT) are effective treatments for cluster B personality disorders (PDs), but few studies have assessed their real-world clinical outcomes in routine practice outside a controlled trial setting. Methods: Our descriptive naturalistic retrospective study evaluated 288 patients with cluster B PDs who predominantly had borderline PD referred to MBT or DBT. Results: Observed changes in emergency department (ED) use and hospitalizations one year before and during the first year of therapy were described for patients with at least one relevant event, along with dropout rates. ED visit analyses concerned 104 patients, and hospitalization analyses concerned 30 patients. Across both treatment modalities, ED visits decreased from 119 in the year prior to treatment to 37 during the first year of treatment (p < .001 for both). Hospitalizations were observed to decrease for patients in MBT (p < .05), while no clear change was seen in the DBT group (p = .595). Drop-out rates during treatment were around 30% in both modalities. Discussion: These patterns descriptively suggest that both therapies are associated with reduced service use during treatment in clinical practice. Future research should investigate which patient- and system-level characteristics can guide patients and clinicians toward the most suitable treatment for everyone, and whether these observed patterns persist beyond the treatment period.


  • Open Access

    Inhibitory control deficits in borderline personality disorder: a meta-analysis of stop-signal and Go/No-Go tasks

    by Nadine Barakat, Jérôme Brunelin, Lionel Cailhol, Andrea Saint-Amant, Luna M. Paoletti, Emmanuel Poulet, Cécilia Neige, William Vallet

    Background: Impulsivity, a multifaceted construct, is a core feature of borderline personality disorder (BPD), associated with functional impairment and suicide mortality. Findings on motor inhibitory control, a key dimension of impulsivity, in BPD are heterogeneous. Methods: This PRISMA-guided meta-analysis examines motor inhibitory control in adults with BPD compared to healthy controls (HCs), using Stop-Signal Task and Go/No-Go Task data. Thirty-seven datasets from 35 articles were included. Results: Results from random-effect models suggest that BPD patients exhibit significantly higher motor inhibitory control deficits than HCs, with a small to moderate effect size. Contrary to common assumptions, a mixed-model effect found that emotional factors did not moderate inhibitory control in BPD. Finally, the meta-analysis revealed that self-reported impulsivity measures did not correlate with task performance, suggesting that subjective and objective measures of impulsivity may assess different facets of the construct. Conclusions: These findings highlight the need for greater standardization of task-based measures of impulsivity, as methodological heterogeneity and quality currently limit replicability across studies.


  • Open Access

    Reinforcing Gaps? A Rapid Review of Innovation in Borderline Personality Disorder (BPD) Treatment

    by Lionel Cailhol, Samuel St-Amour, Marie Désilets, Nadine Larivière, Jillian Mills, Rémy Klein

    Background/Objectives: Borderline Personality Disorder (BPD) involves emotional dysregulation, interpersonal instability and impulsivity. Although treatments have advanced, evaluating the latest innovations remains essential. This rapid review aimed to (1) identify and classify recent therapeutic innovations for BPD, (2) assess their effects on clinical and functional outcomes, and (3) highlight research gaps to inform future priorities. Methods: Employing a rapid review design, we searched PubMed/MEDLINE, PsycINFO, and Embase for publications from 1 January 2019 to 28 March 2025. Eligible studies addressed adult or adolescent BPD populations and novel interventions—psychotherapies, pharmacological agents, digital tools, and neuromodulation. Two independent reviewers conducted screening, full-text review, and data extraction using a standardised form. Results: Sixty-nine studies—predominantly from Europe and North America—were included. Psychotherapeutic programmes dominated, ranging from entirely novel models to adaptations of established treatments (for example, extended or modified Dialectical Behavior Therapy). Pharmacological research offered fresh insights, particularly into ketamine, while holistic approaches such as adventure therapy and digital interventions also emerged. Most investigations centred on symptom reduction; far fewer examined psychosocial functioning, mortality, or social inclusion. Conclusions: Recent innovations show promise in BPD treatment but underserve the needs of mortality and societal-level outcomes. Future research should adopt inclusive, equity-focused agendas that align with patient-centred and recovery-oriented goals, supported by a coordinated, integrated research strategy.


  • Open Access

    Transcranial Direct Current Stimulation (tDCS) for Borderline Personality Disorder (BPD): Why and How?

    by Lionel Cailhol, Kamilia Soltani, Cécilia Neige, Marine Mondino, Jérôme Brunelin, Martin Blay

    Background: Borderline Personality Disorder (BPD) is a severe psychiatric condition characterized by pervasive emotional dysregulation, impulsivity, and unstable interpersonal relationships. Affecting over 1% of the general population, BPD carries significant morbidity, frequent hospitalizations, and an increased risk of suicide. Although specialized psychotherapeutic approaches have shown efficacy, their impact is often constrained by availability, lengthy treatment durations, moderate effect sizes, and high dropout rates. Pharmacological treatments for BPD remain inadequate and are usually accompanied by adverse side effects. Objective: This narrative review seeks to explore the potential of transcranial direct current stimulation (tDCS) as a safe, cost-effective, and accessible neuromodulation intervention aimed at alleviating core BPD symptoms—namely, emotional dysregulation and impulsivity—while also addressing common comorbidities and opportunities for integration with existing therapeutic modalities. Methods: We conducted a narrative literature synthesis in accordance with the SANRA (Scale for the Assessment of Narrative Review Articles) guidelines. A PubMed/MEDLINE search was performed using keywords related to transcranial direct current stimulation (tDCS) and BPD, identifying five published randomized controlled trials on the topic. To provide a broader perspective, we also included studies from related fields examining mechanisms of action, safety and tolerability, cost-effectiveness, stimulation parameters, and clinical outcomes relevant to BPD. Results: Conventional tDCS protocols—typically involving 1–2 mA currents for 20–30 min—have demonstrated an excellent safety profile, resulting in only minimal and transient side effects without any risk of overdose or misuse, which is a key advantage for populations at high risk of suicidality. With moderately priced devices and the feasibility of home-based administration, tDCS provides a substantially more affordable alternative to both long-term pharmacotherapy and intensive psychotherapy. Neurobiologically, tDCS modulates the excitability of the dorsolateral and ventrolateral prefrontal cortex and enhances fronto-limbic connectivity, thereby strengthening top-down regulatory control over emotion and behavior. Pilot randomized controlled trials report moderate effect sizes for improvements in emotional regulation, inhibitory control, and rejection sensitivity, along with ancillary gains in executive functioning and reductions in depressive and substance-use symptoms when stimulating the left dorsolateral prefrontal cortex. Conclusions: tDCS stimulation emerges as a safe and scalable adjunctive treatment for BPD, leveraging targeted neuromodulation to address core features and common comorbidities like depression. However, variability in current protocols and the scarcity of well-powered randomized trials underscore the pressing need for standardized methodologies, longer-term follow-up, and individualized stimulation strategies to establish enduring clinical benefits.